Safety Incidents OSHA Severe Injury Reports · 2015–2025
5,189,992Inspections Most recent open 2026-07-18 Last loaded 2026-07-22

OSHA Inspection: IOVANCE BIOTHERAPEUTICS MANUFACTURING, LLC

Complaint inspection · Health discipline

On , OSHA opened a complaint health inspection of IOVANCE BIOTHERAPEUTICS MANUFACTURING, LLC in 700 SPRING GARDEN STREET, PHILADELPHIA, PA 19123 (NAICS 325412). OSHA activity number 346589187.

What this inspection record means

OSHA opens inspections for many reasons — routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.

Watch Iovance Biotherapeutics Manufacturing, LLC — free Get an email when a new federal OSHA severe-injury report for Iovance Biotherapeutics Manufacturing, LLC is published. One employer, no account, unsubscribe in one click.
Site address
700 SPRING GARDEN STREET
City
PHILADELPHIA
State
PA
ZIP
19123
Mailing
300 ROUSE BLVD, PHILADELPHIA, PA 19112
Inspection type
Complaint (B)
Scope
Partial (B)
Discipline
Health
Advance notice
No
Union status
B
Opened
Closing conference
Case closed
Last modified
Data loaded
NAICS code
325412
Employees
20
Ownership type
A

2 citations on file for this inspection.

1910.134 D01 III

Other-than-serious Gravity 5 1 instance 9 exposed
Issued
Sep 19, 2023
Abate by
Nov 6, 2023
Penalty
Initial $11,162 · Current $11,162

Hazardous substances 1560

29 CFR  1910.134(d)(1)(iii): The employer did not identify and evaluate the respiratory hazard(s) in the workplace; including a reasonable estimate of employee exposures to respiratory hazards and identification of the contaminant's chemical state and physical form:  a) Iovance Biotherapeutics Manufacturing, LLC located at 700 Spring Garden Street Philadelphia PA: On or about March 24, 2023, the employer did not evaluate the respiratory hazards in the workplace, to include measurements of employee exposures to hazardous chemicals such as, but not limited to isopropyl alcohol, sodium hydroxide, etc. while performing disinfecting activities on raw material containers, disposables, equipment, or other materials transferred into controlled manufacturing cleanrooms and support areas.
Recent events (3)
  • — F (O) $11162
  • — C (S) $11162
  • — Z (S) $11162

1904.32 A04

Deleted Other-than-serious 1 instance 22 exposed
Issued
Sep 19, 2023
Abate by
Oct 6, 2023
Penalty
Initial $2,232 · Current $0 Reduced
29 CFR  1904.32(a)(4):The employer did not post an OSHA 300A Form or equivalent by February 1 thru April 30:  (a) Iovance Biotherapeutics Manufacturing, LLC located at  700 Spring Garden Street Philadelphia PA:  On or about March 24, 2023, the employer failed to post the annual summary of work-related injuries and illnesses for calendar year 2022.
Recent events (3)
  • — F (O) $0
  • — C (O) $2232
  • — Z (O) $2232

This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 346589187.

Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.